In May 2023, ZETO Secures ‘Best Neurology Solution of 2023’ Title from MedTech Breakthrough Awards. This prestigious award, presented by MedTech Breakthrough, an independent market intelligence organization, highlights Zeto’s innovation and leadership in the field, reinforcing its commitment to advancing neurology solutions and enhancing patient care.
In October 2021, ZETO won the 2021 UCSF Health Awards in Hospital Diagnostics. “It is an honor to be recognized alongside such impactful companies in Health Care. Our journey to transform EEG and Brain Monitoring is well underway,” said Aswin Gunasekar, the CEO of ZETO.
The UCSF Health Awards recognize the best new products and technologies in digital health and life sciences. This year, more than 450 judges considered over 1,200 submissions to crown just 16 winners.
In 2020, we proudly joined an elite group as one of the five companies selected for the prestigious Health Tech Arkansas Accelerator Program. This honor underscores our commitment to innovation in the healthcare industry and our dedication to improving the future of healthcare services.
HealthTech Arkansas and MedAxiom have come together to create a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.
In July 2019, ZETO won the ‘Top North American Wearable 2019’ award at the Wearable Technologies conference in San Francisco.
Wearable Technologies picked top companies across various industries for the 11TH IOT/WT INNOVATION WORLD CUP®, the world’s leading IoT competition that supports techpreneurs to push their development further and present their ideas to key IoT industry players and investors.
ZETO was honored to be recognized as the leading wearable innovator.
In Nov 2018, ZETO won the MEDY Outstanding Pitch Award at the Exponential Medicine Conference competing with over 80 disruptive health care companies.
The MEDy Awards recognize companies designing products and creating healthcare solutions that are industry-changing innovations. Exponential Medicine explores the cutting edge of technology and its implications for the future of medicine across the healthcare continuum.
After 700+ applications, 14 pitch events in 12 cities, and over 200 industry professionals weighing in, MedTech Innovator selected 2018’s 50 most transformative early-stage device, diagnostic and digital health companies.
ZETO is honored to be one of the Showcase companies of 2018.
ZETO was featured at the WSGR medical device conference in June in San Francisco and at the Advamed MedTech Conference in September in Philadelphia.
In Dec 2017, ZETO won an investment of $200,000 from the Epilepsy Foundation as part of its New Therapy Commercialization Award Program.
We feel honored to have the Epilepsy Foundation on board as an investor. This investment is a testimonial to their belief and commitment to ZETO and we look forward to working with them in commercializing our product.
In Nov 2017, The American Diabetes Association held its 22nd Annual Leaders Forum HealthTech Showcase featuring start-up ventures in the life science and digital health arenas.
ZETO was selected as one of the top 3 companies from over 100 promising companies and presented to an audience of VCs, entrepreneurs and life science executives.
In June 2017, ZETO won the Rosenman Innovator of the Year Award by QB3 a premier life science accelerator in Silicon Valley affiliated to UCSF, UCB and UCSC.
ZETO was recognized as one of the top 10 promising medical technology startups in the California Bay Area.
In May 2017, ZETO won the ‘TiE50 Top Startup Award’ at TiECon 2017, a major Silicon Valley conference attended by over 5000 people every year.
In Feb 2016, ZETO won a maximum award of $150,000 from the Epilepsy Foundation at its Shark Tank Event.
Winning this award was highly gratifying to us since the core audience was a mix of Neurologists, EEG technicians and hospital administrators.